Breaking News

Evestia Clinical Acquires ICRC-Weyer

Strengthens Evestia Clinical's presence in Europe and further enhances its full-service clinical research solutions for biotech innovators.

Author Image

By: Charlie Sternberg

Associate Editor

Evestia Clinical (formerly EMAS Pharma), an independent global specialist Contract Research Organization (CRO), has acquired ICRC-Weyer GmbH, a Berlin-based CRO and scientific consultancy. The acquisition strengthens Evestia Clinical’s presence in Germany and Europe and further enhances the company’s full-service clinical research solutions for biotech innovators. ICRC-Weyer offers experience in data-driven clinical research, with scientific and operational expertise in biostatist...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics